Form 4: Perspective Therapeutics CEO Johan Spoor Acquires 100,000 Shares of Common Stock
SEC Form 4 Filing
Perspective Therapeutics CEO Johan Spoor purchased 100,000 shares of common stock at a weighted average price of $1.1743 on June 13, 2024.
Summary
- On June 13, 2024, Johan M. Spoor, CEO of Perspective Therapeutics, Inc. (CATX), acquired 100,000 shares of common stock.
- The purchase was made at a weighted average price of $1.1743 per share, with prices ranging from $1.1650 to $1.1800.
- Following the transaction, Spoor directly owns 137,572 shares of Perspective Therapeutics common stock.
- Spoor also indirectly owns 60,000 shares through his spouse's IRA and 10,000 shares through a child.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is a positive signal, but the document itself is simply a regulatory filing.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's performance and future prospects. CEO's buying shares is generally seen as a positive sign.
Stakeholder Impact
- Shareholders may view the CEO's purchase as a positive sign, potentially increasing investor confidence.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of the transaction: Johan Spoor purchased 100,000 shares of common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.